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Abstract
Antiviral provision remains the focus of many pandemic preparedness plans, however, there is considerable uncertainty
regarding antiviral compliance rates. Here we employ a waste water epidemiology approach to estimate oseltamivir
(TamifluH) compliance. Oseltamivir carboxylate (oseltamivir’s active metabolite) was recovered from two waste water
treatment plant (WWTP) catchments within the United Kingdom at the peak of the autumnal wave of the 2009 Influenza A
(H1N1)pdm09 pandemic. Predictions of oseltamivir consumption from detected levels were compared with two sources of
national government statistics to derive compliance rates. Scenario and sensitivity analysis indicated between 3–4 and 120–
154 people were using oseltamivir during the study period in the two WWTP catchments and a compliance rate between
45–60%. With approximately half the collected antivirals going unused, there is a clear need to alter public health messages
to improve compliance. We argue that a near real-time understanding of drug compliance at the scale of the waste water
treatment plant (hundreds to millions of people) can potentially help public health messages become more timely,
targeted, and demographically sensitive, while potentially leading to less mis- and un-used antiviral, less wastage and
ultimately a more robust and efficacious pandemic preparedness plan.
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Introduction
An influenza pandemic is regarded as one of the most significant
civil emergency risks with major global human health conse-
quences and the potential to cause significant social and economic
damage and disruption [1,2]. One of the few options for alleviating
the human health burden from an influenza pandemic is the use of
pharmaceuticals such as antivirals. Vaccine provision and non-
pharmaceutical measures (e.g., closing schools and/or borders,
hand-washing) represent two other widely used infection mitiga-
tion approaches employed in national preparedness plans.
Numerous countries world-wide distributed courses of antivirals
for prophylaxis and treatment of influenza-like illness (ILI) during
the 2009 Influenza A(H1N1)pdm09 pandemic, with the majority
of the antiviral stockpiles consisting of oseltamivir (TamifluH) [3].
The United Kingdom Health Protection Agency (HPA)
QSurveillance National Syndromic Surveillance System moni-
tored a range of clinical and syndromic indicators that were
indicative of influenza activity. This system was established when
antiviral drugs were deployed during the pandemic in the U.K.
The National Pandemic Flu Service (NPFS) was responsible for
the provision of information, syndromic diagnosis, and prescrip-
tion and dispensing of antiviral courses in the UK.
Compliance rates to the prescribed antiviral course (i.e., one
dose of Tamiflu per day for prophylaxis and two doses per day for
treatment) was first reported in the U.K. three months after the
outset of the pandemic [4–8]. Compliance was highly varied,
ranging between 48 to 97%, with a narrow age range of study
participants, ,14 yrs of age. To our knowledge, compliance rates
for the period of the second, autumnal wave of the 2009 influenza
pandemic in the U.K. was not collected, nor was there any
significant body of research to draw upon for predicting
compliance in .14 yr olds at any point during the 2009
pandemic. This knowledge gap greatly hinders the ability of
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government and public health planners to proactively address the
problem of compliance and the issues it generates.
Poor compliance drains resources by diverting limited antiviral
stocks from those who may need it most. Mis- and un-used
antivirals can lead to the hastening of antiviral resistance in cases
where influenza-infected people do not comply with the prescribed
course and dosing regimen. The provision of antivirals that remain
unused also represents a significant financial cost to governments
[9]. Antiviral non-compliance can also influence the success of
inter-related public health plans, such as combating secondary
bacterial infections in influenza cases. The provision of antivirals is
expected to decrease the need for antibiotics by an estimated
,50% owing to a reported decline in secondary infections in
antiviral users [3,10,11]. For these reasons, the pandemic
influenza medical response and the national pandemic prepared-
ness plan will remain unnecessarily vulnerable without greater
certainty with respect to human behaviour – more specifically,
antiviral compliance.
Oseltamivir carboxylate (OC; oseltamivirs active metabolite) is
frequently demonstrated to be a conservative chemical in waste-
and fresh-water systems [12–20], and as such, represents an ideal
tracer for the waste water forensic epidemiology approach [21–
23]. In this epidemiological study we evaluated the load of OC in
waste water as an unbiased measure of Tamiflu consumption
during an influenza pandemic. The OC levels in influent of two
waste water treatment plants (WWTPs) located at Benson
(51.61562, 21.10945) and Oxford (51.71384, 21.21545), in
Oxfordshire, England, were measured during the peak of the
2009 Influenza A(H1N1)pdm09 pandemic [24]. Measured OC
was compared with two complementary sources of national
government statistics to assess compliance rates. It is proposed
that an empirically-derived estimate of compliance, recorded in
near-real time, can help to inform and prioritise public health
messages at the spatial resolution of the WWTP catchment, which
can range from a population of a few thousand in rural areas to
over a 1 million in highly urban areas. We argue that this granular
understanding of non-compliance can help public health messages
become more targeted and efficacious, leading to less mis- and un-
used antivirals, cost savings and a more robust preparedness plan.
Methods
Waste Water Sampling
An urban and a rural WWTP were chosen for this study to
reflect potentially different pharmaceutical use patterns in the two
catchment populations. The rural WWTP at Benson England,
serves a population of 6,230 people with a consented dry weather
flow of 2,517 m3/d and an annual average dry weather flow
(DWF) of 1,368 m3/d. The Benson WWTP has a hydraulic
retention time of 7–8 h at dry weather flow and consists of
trickling filters as the main biological treatment step. The urban
WWTP at Oxford serves a population of 208,000 with a consented
dry weather flow of 50,965 m3/d and an annual mean DWF of
38,000 m3/d. The Oxford WWTP has a hydraulic retention time
of 15–18 h, and utilizes activated sludge as the main biological
treatment step. Both WWTPs have primary and secondary
sedimentation steps. The Oxford and Benson sewer systems
receive flow from a number of pumping stations either running in
series to the site along the sewer network or in parallel from sub-
catchments.
Thames Water Utilities Limited provided access to both
WWTP; all necessary permits were obtained for described field
Figure 1. Waste Water Treatment Plant Flow. Hourly flow (m3/h) from Benson (open) and Oxford (shaded) WWTP on sampling days 11
November 2009 (solid line) and 10 May 2011 (dashed line).
doi:10.1371/journal.pone.0060221.g001
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studies, including the Thames Water Operational Safety Autho-
rization (TWOSA). Each WWTP was sampled using an automat-
ed sampler scheduled to recover a time-proportional sample
(approximately 750 mL) of influent every hour for 24 hours.
Sampling commenced at 15:00 on Nov 10th, with the last sample
taken at 14:00 on Nov 11th 2009. At its completion, samples were
stored, in triplicate, in 50-mL borosilicate glass vials with PTFE-
lined caps at 280uC. Samples were shipped frozen to Umea˚
University, Sweden, where they were stored at 220uC until
analysis.
OC was converted to mass loading using hourly WWTP flows
for the sampling period (Figure 1). Flows were determined in
consultation with Thames Water, the WWTP operator. Flows at
both WWTPs peaked between 07:00 to 9:00 and again from 18:00
to 19:00. An additional 24-h sampling was initiated at 10:00 on 15
May, 2011 from only the Benson WWTP effluent for the purpose
of confirming the background concentration of antiviral during the
inter-pandemic period, which officially began on 10 August, 2010
[25].
Environmental Conditions
Precipitation on 11 November, 2009 (3.3 mm) was approxi-
mately 1.0 mm below the monthly average for November
(4.25 mm) [26]. The 24-hour mean flow for Benson WWTP was
1,210 m3/d, 13% below the average annual dry weather flow.
Oxford WWTP’s daily flow was 52,828 m3/d, 28% higher than
the annual average dry weather flow for the same time period. No
precipitation occurred within the previous 48 h of the May 11,
2011 sampling point of the Benson WWTP influent where the
mean 24-h flow was 1556 m3/d. The temperature during the
sampling period ranged from 0.7 to 10.5uC and 6 to 19.6uC over
the November 11, 2009 and May 11, 2011 sampling periods,
respectively [26].
Measurement of OC in Waste Water
An on-line solid phase liquid extraction/liquid chromatogra-
phy-tandem mass-spectrometry (SPE/LC-MS/MS) system was
used to measure the OC levels in the samples collected at Benson
and Oxford WWTPs in southern Oxfordshire, England. The
SPE/LC-MS/MS system used has been evaluated and described
in details previously [27]. Briefly, 1 mL of 5 mL pre-filtered
(0.45 mm pore size) sample was analyzed by the SPE/LC-MS/MS
system. The samples were quantified using a deuterated OC
internal standard, with six calibration points. The limit of
quantification (LOQ) was 2 ng/L.
Predicting Tamiflu Consumption
Two methods were used for predicting Tamiflu consumption
within the two WWTP catchments, based on data from the
National Pandemic Flu Service (NPFS) [24] and the HPA/
QSurveillance National Syndromic Surveillance System (HPA)
[28]. The NPFS recorded the collection of 1,079,179 courses of
antiviral treatment in England between the launch of NPFS in July
2009 to February 2010, when it ceased operation, equating to
,2% of the population. Using these values, an estimated 132
courses of antivirals were dispensed in the Benson WWTP
catchment and 4,401 in the Oxford WWTP catchment over the
same period of time. Approximately 66,218 courses of antiviral
Figure 2. Oseltamivir Carboxylate Concentration in Waste Water. Hourly time-proportional influent concentration of OC (ng/L) in Oxford
WWTP (shaded) and Benson WWTP (open).
doi:10.1371/journal.pone.0060221.g002
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(6% of all antivirals dispensed) were dispensed in Week 43
(3 weeks prior to the WWTP sampling), the national peak for
the autumnal wave of the 2009 influenza pandemic [24], equating
to approximately 0.13% of the population of England receiving
antiviral. An exact amount of antivirals dispensed for Week 46 (the
week of the study) was not available, however, it is estimated that
there was less than a 10% decline in antiviral dispensing by
Week 46, thereby making any antiviral allocation differences
between Week 43 and 46 negligible (see Figure 15 in ref [24] for
antiviral collections during the pandemic). These predictions
translate into: 8 and 270 courses of antiviral collected within the
Benson and Oxford WWTPs catchment during the week of
sampling (10 November, 2009). The following compliance
scenarios were examined: 40, 45, 50, 55, 60, 70 or 100%
compliance (i.e. 40–100% of those collecting Tamiflu would use it,
as directed). The standard dosing regime was assumed: 0.075 g per
dose, consumed twice per day (0.150 g/d).
The HPA dataset reports 54.2 people per 100,000 with ILI in
the Oxfordshire PCT during Week 46 (inclusive of both the
Oxford and Benson WWTP catchments). This prediction trans-
lates to 3?4 and 112?7 cases of ILI in the Benson and Oxford
catchments, respectively. In addition to the seven compliance
scenarios previously mentioned for the NPFS dataset, an
additional scenario was needed for the HPA dataset: 50 or
100% of the cases of ILI were prescribed antiviral. This additional
scenario was examined because only ,50% of ILI cases are
clinically-diagnosed with influenza. The antiviral prescription rate
for ILI might be expected to more closely approximate 100% than
the more clinically-accurate 50% prescription rate, as syndromic
diagnosis prevails during a pandemic, with clinical diagnosis more
the exception than the rule.
Predicted OC Concentrations in Waste wsater
The projected concentration of OC in the waste water (ng/L)
was calculated using Equation 1,
DP|DM
P|L
|109 ð1Þ
where the product of the population of each catchment (P; Benson
= 6230 and Oxford = 208000) and the volume of waste water per
person (L) (230 L) was divided into the product of population
predicted to consume Tamiflu (Dp) and the mass equivalent of OC
consumed per day in grams (DM; 0?15 g/d is the defined daily
dose (DDD) for Tamiflu for treatment purposes).
An additional scenario that assumes either 80 or 100% of the
Tamiflu dose was recovered as OC in WWTP influent was
employed when predicting concentrations of OC in waste water or
back-calculating from waste water to Tamiflu users. This scenario
was employed as 100% of the Tamiflu dose is excreted into the
waste water, with up to 20% in the form of the prodrug
oseltamivir. However, the prodrug can potentially transform in the
waste water to the active antiviral, OC, leading to a theoretical
maximum of 100% of consumed Tamfilu recovered as OC [29].
This scenario was necessary because the parent prodrug was not
monitored in the waste water. If the ratio of parent compound to
active metabolite was found to be approximating 1:4, a default
scenario of 80% would be sufficient.
Figure 3. Oseltamivir Carboxylate Load in Waste Water. Calculated hourly influent load of OC (mg/h) for Oxford WWTP (closed) and Benson
WWTP (open).
doi:10.1371/journal.pone.0060221.g003
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Results
Measured Antiviral Concentrations or Load in Waste
water
The concentration of OC in the influent of Benson WWTP
ranged from 59 to 2,070 ng/L, with a mean of 3946435 ng/L
(Figure 2). The average load for the 24 h period was
490626.9 mg/h (Figure 3). The concentration of OC in the
influent of Oxford WWTP ranged from 257 to 550 ng/L, with a
mean of 350660 ng/L (Figure 2). The average load for the 24 h
period was 17,9796179 mg/h (Figure 3). OC was not recovered
(,2.0 ng/L) in the effluent of Benson WWTP during the ‘inter-
pandemic’ sampling period, as anticipated.
Predicted Use of Antiviral from Scenarios
When the full range of compliance (40, 45, 50, 55, 60, 70,
100%) and antiviral allocation rates (50 or 100% of ILI cases) were
considered using the HPA population statistics, the Tamiflu-using
population was predicted to be between 1.35 and 3.37 people in
Benson and 45.1 and 112.7 people in Oxford WWTP catchments
(0.02–0.05% of the respective catchment populations; Figure 4).
When the full range of compliance scenarios were considered
using the NFPS Tamiflu allocation statistics, the Tamiflu-using
population was predicted to be between 3.24 and 8.09 people in
Benson and 108 and 270 in Oxford WWTP catchments,
respectively (0.05–0.13% of the respective catchment populations;
Figure 4).
Predicted Antiviral released into Waste Water from
Scenarios
Predicted concentrations of OC in the Benson and Oxford
WWTP (calculated using Equation 1 including all scenarios
discussed in the Material & Methods Section), range from 57 to
847 ng/L (Figure 5). HPA-based scenarios ranged from 57 to
282 ng/L, while NPFS-based scenarios ranged from 270 to
846 ng/L. All the HPA-based scenarios yielded OC concentra-
tions below the measured concentration for Benson (mean
394 ng/L), while only one scenario exceeded the measured
concentration for Oxford (mean 350 ng/L). This one scenario
was the most conservative, assuming: 100% compliance, 100% of
ILI cases were allocated antiviral, and 100% of Tamiflu was
recoverable as OC (353 ng/L). Given the unlikely nature of these
conservative assumptions, it is argued that the NFPS dataset is a
better reflection of antiviral use in the community.
Predicted Consumption of Antiviral from Measured Load
Measured concentrations of OC were converted to units of
Tamiflu users per day. All calculations considered the possibility
that the measured concentration of OC reflects either 80 or 100%
of the daily dose (0.15 g/d), and in the case of the HPA dataset, it
also considered the option that either 50 or 100% of people
recorded with ILI were prescribed antiviral. Predicted Tamiflu use
from the total 24-h load of OC ranged from 3 to 4 people (0.5–
0.6% of the catchment population) in the Benson WWTP
catchment and from 120 to 154 people (0.6 to 0.7%) in the
Figure 4. Scenario projections for Tamiflu-consumption. Tamiflu consumption during the 24 hour influent sampling at Oxford (A) and Benson
(B) WWTPs based on HPA or NPFS statistics and varying compliance, Tamiflu metabolism, and ILI prescription rates were as detailed in the Materials
and Methods. Load represents back-calculated predicted number of Tamiflu users for the 24-h sampling period assuming 80 or 100% OC in the waste
stream. The mean of the scenarios is represented by a shaded triangle.
doi:10.1371/journal.pone.0060221.g004
Oseltamivir Compliance during Influenza Pandemic
PLOS ONE | www.plosone.org 5 April 2013 | Volume 8 | Issue 4 | e60221
Oxford WWTP catchment (Figure 4). Projections remained
consistent even when the 24-h mean concentration was used in
lieu of load (3 to 4 and 123 to 154 people for Benson and Oxford,
respectively).
Discussion
In this study, Tamiflu use and compliance were predicted from
measured OC in waste water influent and through the use of
national government statistics on cases of ILI (HPA) and antiviral
dispensing (NFPS). Measured concentrations of OC in waste water
were consistent with NFPS-derived scenarios. This is not
surprising given that NFPS statistics reflect actual antiviral
dispensing, albeit at a spatial scale of the UK (62 million), quite
dissimilar from the spatial scale of the WWTP (i.e. 6,230 and
240,000 people). HPA-derived scenarios were shown to routinely
underestimate Tamiflu use, reflecting the fact that this statistic is
derived from regional case rates of ILI determined from patient
visits to the general practitioner (GP). Owing to the syndromic
diagnosis of ILI during the pandemic via the NPFS website and
phone hotline, the HPA-ILI statistic reflects only a fraction of the
national ILI-population, as visits to the GP were actively
discouraged once the NPFS was fully operational in late-July
2009 [24].
The recovered oseltamivir carboxylate in the Benson and
Oxford WWTP catchments during the peak of the autumnal wave
in southern England can be best explained by a compliance rate of
45–60% based on NPFS estimates of oseltamivir collection
(Figure 5). In a recent study, Singer et al. (2011) modelled Tamiflu
use and environmental concentrations of OC during an influenza
pandemic of differing severities: R0 = 1.65, 1.9 and 2.3, with
R0 = 1.65 being a good reflection of the 2009 influenza pandemic
(R0 is the basic reproductive number reflecting the number of
cases one case generates on average over the course of their
infectious period). Extrapolating from Singer et al. (2011), a
pandemic of R0 = 1.65 was projected to generate one Tamiflu user
within the Benson WWTP catchment and 168 people within the
Oxford WWTP catchment on the day of the peak of the
pandemic. The model scenario assumes negligible antiviral
prophylaxis and the provision of antivirals for treatment of 30%
of those with access to antivirals [3]. Projections by Singer et al
(2011) were entirely consistent with national antiviral allocation
statistics and estimates generated in this study using the waste
water epidemiology approach.
Figure 5. Scenario predictions of OC influent concentration (ng/L). Scenario codes can be interpreted as follows: percent of ILI cases
prescribed OC, used only when HPA data was employed (assumed = 100, unless specified as 50)/Source of data (NPFS or HPA)/percent compliance
(40, 45, 50, 55, 60, 70, 100%)/percent of parent compound converted to OC before WWTP inlet (80, 100%)/O = Oxford WWTP and B = Benson WWTP.
Mean 24-h OC concentrations at Benson and Oxford are noted by the WWTP name, only. Daily water usage was assumed to be the UK national
average of 230 L/capita [3].
doi:10.1371/journal.pone.0060221.g005
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The variability in load and concentration of OC in the Benson
WWTP influent (relative standard deviation (RSD) = 132 and
110%, respectively) was much greater than that of Oxford (RSD
= 23 and 17%, respectively). This variability is, to a large extent, a
function of the difference in population between Benson and
Oxford ( 6230 and 208,000 respectively). Assuming, on average, a
person flushes the toilet five times a day [30], the number of
flushes per user of Tamiflu (i.e., doses65) in Benson ranges from
6.5 to 40 and 225 to 1350 in Oxford (based on NPFS estimates).
The low number of flushes per day in Benson and for some
scenarios in Oxford would make it difficult to get a representative
sampling of Tamiflu users in these catchments using hourly time
proportional sampling. A theoretical threshold of 1000 flush events
per chemical within a WWTP catchment was proposed as a guide
for the minimum flush events needed to justify the use of a time-
proportional hourly sampling frequency [30]. Catchments with
fewer flush events per day might require more frequent sampling
to ensure measured analytes were representative of the pharma-
ceutical use habits of the catchment population. However, the
pumped nature of both of these waste water systems contributes to
the mixing of discrete flushing events, particularly important in the
smaller Benson catchment during off-peak flow periods. We argue
this mixing in the waste water system has alleviated some of the
variability associated with sampling small populations at an hourly
time interval. However, future studies should give suitable
consideration towards minimising the confounding effects of the
population size on the waste water sampling.
Antiviral compliance during the 2009 Influenza
A(H1N1)pdm09 pandemic has been estimated in a few countries
worldwide, most of which were assessed during the early phase of
the pandemic on a very small demographic. A study in England
examined the degree to which 11–12 yr old pupils of a secondary
school complied with a 10-day prophylaxis (once-daily) dosing
regimen of Tamiflu at the outset of the pandemic in the UK (April
29, 2009) [4]. The authors found compliance was very high, with
77% taking the full course of Tamiflu [4]. A considerably lower
compliance rate of 48% was estimated in a subsequent study that
also investigated pupils of a similar age (14 yr) at a boarding school
[5]. An online survey of pupils from one primary and two
secondary schools in London at the outset of the pandemic in the
UK reported only 48% of primary schoolchildren completed a full
prophylaxis course, compared to 76% of secondary schoolchildren
[6]. A study of compliance in 1–11 yr olds within a nursery,
primary school and afterschool club in Scotland reported 97% of
the children completed the full prophylaxis regime [7]. The
authors proposed that the high compliance might have been
related to the socioeconomic status of the population under
investigation. Fifty-three (adult) staff and 273 pupils (7–12 yrs old)
at a primary school in Sheffield, England were provided Tamiflu
for prophylaxis during the latter part of the first wave of the
pandemic in the UK (June, 2009) [8]. Of this group, 84% of the
pupils and 80% of the staff completed the course of antivirals. It is
clear that the survey approach will always be biased towards a
demographic and limited in it’s scope. In an effort to address these
limitations, (web-based) surveys have been implemented during or
shortly after the pandemic (e.g., Flusurvey [31,32]) to fill the
knowledge gap. However, such approaches are still biased and
thus must be balanced with other sources of information. Here we
present the sampling of waste water treatment plant influent as an
unbiased method for the determination of drug use and
compliance. This study represents the only published report of
non-survey based oseltamivir compliance globally and the first
report on oseltamivir compliance for the second wave of the
pandemic in the UK. Estimated compliance from this study is
consistent with the lower range of published compliance rates. The
integrated sampling from waste water is proposed as a better
measure of compliance as compared to surveys, as this study
incorporates all age groups in an unbiased manner, while survey-
based studies typically focused on a limited sample size and narrow
demographic (,14 year olds).
The accuracy of a waste water epidemiology model for
determining drug use and compliance is potentially confounded
by inappropriate drug disposal into the waste water itself. In most
cases, the active drug that is consumed is excreted into waste water
over a period of several hours. In the case of inappropriate drug
disposal, the entire dose enters the waste water at once.
Presumably when one disposes of drugs in this manner, it entails
the disposal of multiple doses at once. Such a bolus of drug might
appear realistic if only one waste water sample was taken owing to
potential uncertainties with respect to compliance, biodegradation
and prescription rates. However, the bolus would appear
completely unfeasible with sufficiently high sampling frequency
as the quantity of drug passing per unit time would, in comparison
to other time points, be unachievable on a per capita basis [30,33].
Additional supporting evidence for the origin of OC in waste
water can come from measuring the ratio of OC:OP, as described
in a number of previous studies [17,34,35]. However, as OC (the
active antiviral) is generated from the prodrug oseltamivir
phosphate (OP), it can be assumed that all OC found in waste
water in this study was the result of the consumption and (in vivo)
metabolism of the prodrug.
In summary, we propose waste water forensics can be a valuable
tool in monitoring population behaviour and a valuable resource
for public health planning. Insight into the proportion of the
population that does not utilise allocated antiviral or is not
compliant with the dosing regimen could help to inform the
development and prioritization of public health provisioning
during an influenza pandemic. Owing to the fact that the unit
of measurement is a WWTP catchment, the public health message
can be targeted and focused towards a particular demographic,
with potentially greater efficacy and cost savings. More resolved
statistics on the provision of antivirals at the level of the WWTP
catchment (e.g., Primary Care Trust) would further improve the
power of the model. The forensic epidemiological approach
employed in this study might also be applicable to other
pharmaceuticals that are highly conserved in the waste stream
for which compliance rates are in question.
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